System Alert

The will be completely unreachable due to scheduled maintenance from Friday, 05/21/2021 4:00 PM through Monday, 05/24/2021 9:00 AM EST. The New organization registration and DUNS validation process in EHBs will be unavailable during this time.

Skip to Main Content

HRSA Electronic Handbooks

Funding Cycle View


Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN)

  • Program Name:Regional Genetics Networks
  • Activity Code:UH7
  • Application Available:4/22/2021
  • Application Deadline:6/7/2021
  • Created By:Schwab, Dawn
  • Created On:3/9/2021
  • Last Updated by:Wildberger, William
  • Last Updated On:4/22/2021
  • Estimated Project Start Date:6/8/2021

 Details of the changes posted in this announcement

Not Available

 Announcement Information

Announcement Number HRSA-21-110
Announcement Code
CFDA Number 93.110
Provisional No
Activity Code UH7
Competitive Yes
Fiscal Year 2021


This notice announces the opportunity to apply for supplemental funding under the Regional Genetics Networks (RGN) program (HRSA-20-046). The purpose of this Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Network (EGGMIO-RGN) project is to evaluate the implementation and outcomes of selected RGN program activities aimed to improve access to services for individuals with, or at risk for, genetic or genomic conditions1 and their families, especially those among underserved populations. This evaluation will be used to inform the RGN recipients and the field of genetic and genomic medicine with best practices and strategies to implement genetic and genomic advances into clinical and public health. HRSA will fund up to three awards, and each RGN recipient will plan and conduct a focused, rigorous evaluation of implementation and/or outcomes of one or more of their program activities to study their utility, applicability, and effectiveness. The evaluation should focus on one or more strategies the RGN is implementing to meet the goals of the RGN program and not a new activity. Example topics of interest include, but are not limited to, evaluating: • Strategies to outreach and engage primary care providers and non-geneticists to provide additional resources, education, or training to improve their ability to use genomics for the care of their patients. • Perceived clinical utility by providers or individuals and families of RGN-developed genetic or genomic resource(s) throughout the lifecycle of diagnosis, treatment, and management. • Implementation and clinical outcomes of RGN-supported genetic or genomic services offered through nontraditional modalities, such as telehealth. • Applicability of RGN developed resources or strategies across regions and subsequent dissemination of lessons learned across the regions. Examples include adaptation of a strategy through multi-RGN collaboration to address unmet needs common across regions or expanding implementation of the strategy to multiple regions. • Impact of integrating the latest scientific evidence relevant to the genetic or genomic condition to improve the utility, applicability and/or effectiveness of the RGN program activity.

 Legislative Information

Public Health Service Act, Title VI, § 1109(a)(2) and (4) (42 U.S.C. 300b-8(a)(2) and (4))

 Application Information

Application Available 04/22/2021
Application Deadline 06/07/2021
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 08/06/2021
Letter of Intent Not required
Application Package SF424
Allow Applications to be Reopened in EHBs No
FOA Available Yes
Competitive Application Types Supported Continuation & Supplement
Allow Electronic Submission N/A
Page Limit for Application
Allow Multiple Applications
from an Organization from
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 06/08/2021
Estimated Project End Date 05/31/2024
Estimated Amount of this Competition $495,000.00
Estimated Number of Awards 3
Estimated Average Size of Awards $0.00
Cost Sharing No
Cooperative Agreement Yes

 Contact Information

Name Soohyun Kim
Phone Number (301) 594-4202

 Download Information

Expand FOA (Guidance) Attachment (Maximum 1)
Document Name Size Date Attached Description
MCHB HRSA-21-110 (UH7) RGN_Final.pdf 355 kB 04/22/2021
Expand Application Package (Maximum 1)
No documents attached
Expand User Guide (Maximum 1)
No documents attached

Scroll to top